Augmentation of coronary flow reserve in patients with type 2 diabetes mellitus: Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker

被引：0
|
作者：
Kawata, T
Toyoda, T
Hasegawa, R
Teramoto, K
Sekine, T
Maekawa, S
Lee, K
Uchida, D
Himi, T
Kuwabara, Y
机构：
[1] Chiba Univ, Grad Sch Med, Chiba, Japan
[2] Kimitsu Chuo Hosp, Kisarazu, Japan
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2002
引用
收藏
页码：425 / 425
页数：1
相关论文
共 50 条
  • [21] Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With Proteinuria
    Chu, Chi D.
    Powe, Neil R.
    Estrella, Michelle M.
    Shlipak, Michael G.
    McCoy, Ian E.
    Tuot, Delphine S.
    MAYO CLINIC PROCEEDINGS, 2022, 97 (11) : 2099 - 2106
  • [22] Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure
    Struckman, DR
    Rivey, MP
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (02) : 242 - 248
  • [23] Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide
    Sata, N
    Tanaka, Y
    Suzuki, S
    Kamimura, R
    Mifune, H
    Nakamura, K
    Miyahara, K
    Arima, T
    CIRCULATION JOURNAL, 2003, 67 (12) : 1053 - 1058
  • [24] Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
    Jun, Hye-Ran
    Kim, Hyunah
    Lee, Seung-Hwan
    Cho, Jae Hyoung
    Lee, Hyunyong
    Yim, Hyeon Woo
    Yoon, Kun-Ho
    Kim, Hun-Sung
    CARDIOVASCULAR THERAPEUTICS, 2021, 2021
  • [25] Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
    Zhang, Chao
    Zhong, Jun
    Chen, Wei-Xiang
    Zhang, Xu-Yang
    Li, Yu-Hong
    Zhou, Teng-Yuan
    Zou, Yong-Jie
    Lan, Chuan
    Li, Lan
    Lai, Zhao-Pan
    Feng, Hua
    Hu, Rong
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 355 - 363
  • [26] COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy
    Kussmaul, William G., III
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (03) : 237 - 238
  • [27] Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis
    Shen, Jenny I.
    Saxena, Anjali B.
    Montez-Rath, Maria E.
    Chang, Tara I.
    Winkelmayer, Wolfgang C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (05) : 862 - 869
  • [28] Assessment of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker on the split renal function in the patients with primary hypertension
    Zhang, Jingsi
    Wang, Mingyu
    Sun, Kehui
    Ding, Yanchun
    MEDICINE, 2021, 100 (20) : E25928
  • [29] Angiotensin-converting enzyme gene and diabetes mellitus
    Kennon, B
    Petrie, JR
    Small, M
    Connell, JMC
    DIABETIC MEDICINE, 1999, 16 (06) : 448 - 458
  • [30] A comparison of angiotensin-converting enzyme inhibitor and Angiotensin II type 1 receptor blocker on carotid artery intima and media thickness in hypertensives
    Uchiyama-Tanaka, Y
    Matsubara, H
    Mori, Y
    Murasawa, S
    Shibasaki, Y
    Iwasaka, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 241A - 241A
12345